MSL
SGEN

Mackay Shields LLC’s Seagen Inc. Common Stock SGEN Stock Holding History

Mackay Shields LLC’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-48,565
Closed -$6.74M – 1408
2021
Q1 		$6.74M Buy
48,565
+2,403
+5% +$387K 0.05% 401
2020
Q4 		$8.09M Buy
46,162
+27,800
+151% +$5.18M 0.06% 356
2020
Q3 		$3.59M Buy
18,362
+16,915
+1,169% +$2.83M 0.02% 534
2020
Q2 		$246K Buy
+1,447
New +$216K ﹤0.01% 1344
2020
Q1 		– Sell
-1,747
Closed -$200K – 1523
2019
Q4 		$200K Buy
+1,747
New +$185K ﹤0.01% 1264

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mackay Shields LLC's SGEN Position: Q2 2021 in Review

Mackay Shields LLC sold out of Seagen Inc. Common Stock (SGEN) in Q2 2021, closing a stake of 48,565 shares — an estimated $6.74M sold.

Mackay Shields LLC first reported a position in SGEN in Q4 2019 and held it in 5 quarters. The position peaked at $8.09M in Q4 2020. 477 funds tracked by Wall St. Rank hold SGEN as of Q2 2021.

  • Mackay Shields LLC reported no remaining Seagen Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 48,565 Seagen Inc. Common Stock shares in Q2 2021, an estimated $6.74M.
  • Mackay Shields LLC first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Mackay Shields LLC's Seagen Inc. Common Stock position peaked at $8.09M in Q4 2020.
  • 477 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.